Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 Sep 28;313(7060):779–784. doi: 10.1136/bmj.313.7060.779

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

P Rossing 1, P Hougaard 1, K Borch-Johnsen 1, H H Parving 1
PMCID: PMC2352213  PMID: 8842069

Abstract

OBJECTIVE: To evaluate the prognostic significance of microalbuminuria and overt diabetic nephropathy and other putative risk factors for cardiovascular and all cause mortality in insulin dependent diabetes. DESIGN: Ten year observational follow up study. SETTING: Outpatient diabetic clinic in a tertiary referral centre. SUBJECTS: All 939 adults with insulin dependent diabetes (duration of diabetes five years or more) attending the clinic in 1984; 593 had normal urinary albumin excretion (< or = 30 mg/24 h), 181 persistent microalbuminuria (31-299 mg/24 h), and 165 overt nephropathy (> or = 300 mg/24 h). MAIN OUTCOME MEASURE: All cause and cardiovascular mortality. RESULTS: Fifteen per cent of patients (90/593) with normoalbuminuria, 25% (45/181) with microalbuminuria, and 44% (72/165) with overt nephropathy at baseline died during follow up. Cox multiple regression analysis identified the following significant predictors of all cause mortality: male sex (relative risk 2.03; 95% confidence interval 1.37 to 3.02), age (1.07; 1.06 to 1.08), height (0.96; 0.94 to 0.98), smoking (1.51; 1.09 to 2.08), social class V versus social class IV (1.70; 1.25 to 2.31), log10 urinary albumin excretion (1.45; 1.18 to 1.77), hypertension (1.63; 1.18 to 2.25), log10 serum creatinine concentration (8.96; 3.34 to 24.08), and haemoglobin A1c concentration (1.11; 1.03 to 1.20). Age, smoking, microalbuminuria, overt nephropathy, and hypertension were significant predictors of cardiovascular mortality. Mortality in patients with microalbuminuria was only slightly increased compared with that in patients with normoalbuminuria. Median survival time after the onset of overt diabetic nephropathy was 13.9 years (95% confidence interval 11.8 to 17.2 years). CONCLUSIONS: Abnormally increased urinary albumin excretion and other potentially modifiable risk factors such as hypertension, smoking, poor glycaemic control, and social class predict increased mortality in insulin dependent diabetes. Microalbuminuria by itself confers only a small increase in mortality. The prognosis of patients with overt diabetic nephropathy has improved, probably owing to effective antihypertensive treatment.

Full text

PDF
779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983 Dec;25(6):496–501. doi: 10.1007/BF00284458. [DOI] [PubMed] [Google Scholar]
  2. Borch-Johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985 Aug;28(8):590–596. doi: 10.1007/BF00281993. [DOI] [PubMed] [Google Scholar]
  3. Borch-Johnsen K., Wenzel H., Viberti G. C., Mogensen C. E. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ. 1993 Jun 26;306(6894):1722–1725. doi: 10.1136/bmj.306.6894.1722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deckert T., Poulsen J. E., Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978 Jun;14(6):363–370. doi: 10.1007/BF01228130. [DOI] [PubMed] [Google Scholar]
  5. Feldt-Rasmussen B., Mathiesen E. R., Jensen T., Lauritzen T., Deckert T. Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia. 1991 Mar;34(3):164–170. doi: 10.1007/BF00418270. [DOI] [PubMed] [Google Scholar]
  6. Forsblom C. M., Groop P. H., Ekstrand A., Groop L. C. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ. 1992 Oct 31;305(6861):1051–1053. doi: 10.1136/bmj.305.6861.1051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gall M. A., Borch-Johnsen K., Hougaard P., Nielsen F. S., Parving H. H. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995 Nov;44(11):1303–1309. doi: 10.2337/diab.44.11.1303. [DOI] [PubMed] [Google Scholar]
  8. Gould M. M., Mohamed-Ali V., Goubet S. A., Yudkin J. S., Haines A. P. Microalbuminuria: associations with height and sex in non-diabetic subjects. BMJ. 1993 Jan 23;306(6872):240–242. doi: 10.1136/bmj.306.6872.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hebert P. R., Rich-Edwards J. W., Manson J. E., Ridker P. M., Cook N. R., O'Connor G. T., Buring J. E., Hennekens C. H. Height and incidence of cardiovascular disease in male physicians. Circulation. 1993 Oct;88(4 Pt 1):1437–1443. doi: 10.1161/01.cir.88.4.1437. [DOI] [PubMed] [Google Scholar]
  10. Jarrett R. J., Viberti G. C., Argyropoulos A., Hill R. D., Mahmud U., Murrells T. J. Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med. 1984 May;1(1):17–19. doi: 10.1111/j.1464-5491.1984.tb01915.x. [DOI] [PubMed] [Google Scholar]
  11. Knowles H. C., Jr Long-term juvenile diabetes treated with unmeasured diet. Trans Assoc Am Physicians. 1971;84:95–101. [PubMed] [Google Scholar]
  12. Krolewski A. S., Kosinski E. J., Warram J. H., Leland O. S., Busick E. J., Asmal A. C., Rand L. I., Christlieb A. R., Bradley R. F., Kahn C. R. Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol. 1987 Apr 1;59(8):750–755. doi: 10.1016/0002-9149(87)91086-1. [DOI] [PubMed] [Google Scholar]
  13. Krolewski A. S., Warram J. H., Christlieb A. R., Busick E. J., Kahn C. R. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985 May;78(5):785–794. doi: 10.1016/0002-9343(85)90284-0. [DOI] [PubMed] [Google Scholar]
  14. Marmot M. G., Shipley M. J., Rose G. Inequalities in death--specific explanations of a general pattern? Lancet. 1984 May 5;1(8384):1003–1006. doi: 10.1016/s0140-6736(84)92337-7. [DOI] [PubMed] [Google Scholar]
  15. Mathiesen E. R., Borch-Johnsen K., Jensen D. V., Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia. 1989 Dec;32(12):884–886. doi: 10.1007/BF00297455. [DOI] [PubMed] [Google Scholar]
  16. Mathiesen E. R., Hommel E., Giese J., Parving H. H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ. 1991 Jul 13;303(6794):81–87. doi: 10.1136/bmj.303.6794.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Messent J. W., Elliott T. G., Hill R. D., Jarrett R. J., Keen H., Viberti G. C. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int. 1992 Apr;41(4):836–839. doi: 10.1038/ki.1992.128. [DOI] [PubMed] [Google Scholar]
  18. Mogensen C. E., Chachati A., Christensen C. K., Close C. F., Deckert T., Hommel E., Kastrup J., Lefebvre P., Mathiesen E. R., Feldt-Rasmussen B. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest. 1985;9(2):85–95. doi: 10.3109/08860228509088195. [DOI] [PubMed] [Google Scholar]
  19. Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. doi: 10.1056/NEJM198407123110204. [DOI] [PubMed] [Google Scholar]
  20. Mogensen C. E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984 Feb 9;310(6):356–360. doi: 10.1056/NEJM198402093100605. [DOI] [PubMed] [Google Scholar]
  21. Moss S. E., Klein R., Klein B. E., Meuer S. M. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med. 1994 Nov 14;154(21):2473–2479. [PubMed] [Google Scholar]
  22. Parving H. H., Hommel E., Mathiesen E., Skøtt P., Edsberg B., Bahnsen M., Lauritzen M., Hougaard P., Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J (Clin Res Ed) 1988 Jan 16;296(6616):156–160. doi: 10.1136/bmj.296.6616.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Parving H. H., Hommel E. Prognosis in diabetic nephropathy. BMJ. 1989 Jul 22;299(6693):230–233. doi: 10.1136/bmj.299.6693.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Parving H. H., Jacobsen P., Rossing K., Smidt U. M., Hommel E., Rossing P. Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int. 1996 Jun;49(6):1778–1782. doi: 10.1038/ki.1996.266. [DOI] [PubMed] [Google Scholar]
  25. Parving H. H., Oxenbøll B., Svendsen P. A., Christiansen J. S., Andersen A. R. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982 Aug;100(4):550–555. doi: 10.1530/acta.0.1000550. [DOI] [PubMed] [Google Scholar]
  26. Reichard P., Nilsson B. Y., Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304–309. doi: 10.1056/NEJM199307293290502. [DOI] [PubMed] [Google Scholar]
  27. Rossing P., Tarnow L., Nielsen F. S., Boelskifte S., Brenner B. M., Parving H. H. Short stature and diabetic nephropathy. BMJ. 1995 Feb 4;310(6975):296–297. doi: 10.1136/bmj.310.6975.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sawicki P. T., Mühlhauser I., Didjurgeit U., Baumgartner A., Bender R., Berger M. Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy. J Hypertens. 1995 Aug;13(8):933–938. doi: 10.1097/00004872-199508000-00015. [DOI] [PubMed] [Google Scholar]
  29. Viberti G., Mogensen C. E., Groop L. C., Pauls J. F. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA. 1994 Jan 26;271(4):275–279. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES